CEO, Skeletal Dysplasias (QED Therapeutics)

CEO and Founder

JPM26: Beam, Cabaletta, More Zero In on Regulatory Alignment After Tumultuous Year

Financings for Jan. 16, 2026

BridgeBio Announces Commercial Progress, Program Updates, and 2026 Milestones at the 44th Annual J.P. Morgan Healthcare Conference

BridgeBio to Participate in the J.P. Morgan Healthcare Conference

Patient Access Liaison

BridgeBio is a pioneering biotech company focused on developing life-changing medicines for patients with unmet needs. The Patient Access Liaison will engage with patients and care partners on access, affordability, and reimbursement processes for BridgeBio's portfolio of commercialized assets, while collaborating with various internal teams to ensure a positive patient journey.

Patient Access Liaison, South Central in united states (1000+)

Patient Access Liaison, South Central